FDA Approved: PROCRIT — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

The FDA approved a supplemental application for PROCRIT (erythropoietin/epoetin alfa) from Janssen Products, LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Anemia Due to Cancer Chemotherapy
• Anemia Due to Chronic Kidney Disease

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

SUPPL AP for PROCRIT (ERYTHROPOIETIN)